Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation-Reference-Cited by-同舟云学术

Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation

Published:2017-03-13 Issue:6 Volume:31 Page:22120
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Kocyigit Duygu¹,Gurses Kadri Murat²,Yalcin Muhammed Ulvi³,Canpinar Hande⁴,Canpolat Ugur¹,Evranos Banu¹,Yorgun Hikmet¹,Ozer Necla¹,Guc Dicle⁴,Aytemir Kudret¹

Affiliation:

1. Department of Cardiology; Hacettepe University Faculty of Medicine; Ankara Turkey

2. Cardiology Clinics; Konya Training and Research Hospital; Konya Turkey

3. Department of Cardiology; Selcuk University Faculty of Medicine; Konya Turkey

4. Department of Basic Oncology; Hacettepe University Cancer Institute; Ankara Turkey

Funder

Hacettepe University Scientific Research Projects Coordination Unit

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference29 articles.

1. Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke;Jones;Am J Cardiol,1996

2. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation;Kamp;Eur Heart J,1999

3. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators;Zabalgoitia;J Am Coll Cardiol,1998

4. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study);Asinger;J Am Soc Echocardiogr,1999

5. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study);Goldman;J Am Soc Echocardiogr,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Galectin-3’s Role in Diastolic Dysfunction: A Contemporary Perspective;Life;2024-07-20

2. An overview about galectin-3 and its relationship with cardiovascular diseases;Journal of Surgery and Medicine;2021-12-01

3. The effect of left atrial appendage closure on heart failure biomarkers: A PRAGUE‐17 trial subanalysis;Journal of Cardiovascular Electrophysiology;2021-08-26

4. Potential Biomarkers in Atrial Fibrillation: Insight Into Their Clinical Significance;Journal of Cardiovascular Pharmacology;2021-08

5. Biomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion;Kardiologia Polska;2021-03-25